Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine + midazolam versus propofol + midazolam for pediatric gastroduodenoscopy sedation
IRCT20230228057558N1Phase 4Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gastrointestinal conditions comparing Midazolam + propofol with Midazolam + ketamine (2 arms). Primary endpoints: Blood pressure, Heart rate and 1 more. Started Nov 2023; status: completed.
02
Drugs
ketaminemidazolampropofol
03
Conditions
gastrointestinal conditions
Beyond the preview
Go deeper on IRCT20230228057558N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230228057558N1.